Search This Section
Framework
Showing 1-3 of 3
Date Published: 03.02.2023
FREQUENTLY ASKED QUESTIONS - NON-CDL CLASSIFICATION FRAMEWORK
Please refer to the Frequently Asked Questions for more information on the Non-CDL Classification Framework.
Industry Guidelines -
Framework
FAQs_Non-CDL Classification Framework_Draft_1Feb23.pdf
(PDF, 0.23MB)
Date Published: 03.02.2023
SPECIFIC LINKS TO INTEGRATED SHIELD PLANS (IPs) AND IP RIDER COVERAGE OF CANCER DRUG TREATMENTS AND SERVICES
More details on IPs and IP rider coverage of cancer drug treatments and services can be found in the respective IP Insurer’s webpage.
Industry Guidelines -
Framework
Insurers URLs_IPs and IP Riders.pdf
(PDF, 0.20MB)
Date Published: 02.09.2022
Classification of Cancer Drug Treatments Which Are Not On The MOH Cancer Drug List (“Non-CDL Classification Framework”)
Effective: 1 April 2023 For more details on the "Non-CDL Classification Framework", please refer to Appendix A.
Industry Guidelines -
Framework
Non-CDL Classification Framework.pdf
(PDF, 0.26MB)